REFERENCES
1. Harlow SD, Lin X, Ho MJ. Analysis of menstrual diary data across the reproductive life span. Applicability of the bipartite model approach and the importance of within woman variance.
J Clin Epidemiol 2000;53:722-33.2. Fraser IS, Sungurtekin-Inceboz U. Defining disturbances of the menstrual cycle. In: O’Brien PMS, Cameron IT, MacLean AB (eds), Disorders of the Menstrual Cycle, pp 141-52. London: RCOG Press, 2000.
3. Fraser IS, Critchley HO, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? Hum Reprod 2007;22:635-43.
4. Munro MG, Critchley HOD, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO Classification System (PALM- COEIN) for causes of abnormal uterine bleeding in non-gravid women of reproductive age. Int J Gynecol Obstet 2011;113:3-13.
5. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss—a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45:320-51.
6. Cole SK, Billewicz WZ, Thomson AM. Sources ofvariation in menstrual blood loss. J Obstet Gynaecol BrCommonw 1971;78:933-39.
7. National Institute for Health and Care Excellence (NICE). Heavy Menstrual Bleeding: Assessment and Management. NICE guideline [NG88]. London: NICE; 2007. Available at: https://www.nice.org. uk∕guidance∕ng88.
8. Tan DA, Haththotuwa R, Fraser IS. Cultural aspects and mythologies surrounding menstruation and abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol 2017;40:121-33.
9. Shander A, Hofmann A, Isbister J, Van Aken H. Patient blood management—the new frontier. Best Prac Res Clin Anaesthesiol 2013;27:5-10.
10. Clevenger B, Mallett SV, Klein AA, Richards T. Patient blood management to reduce surgical risk.
Br J Surg 2015;102:1325-37.11. Caronia LM, Martin C, Welt CK. A genetic basis for functional hypothalamic amenorrhea. N Engl J Med 2011;301:215-25.
12. Codner E, Merino PM, Tena-Sempere M. Female reproducotion and type 1 diabetes: from mechanisms to clinical findings. Hum Reprod Update 2012;18:568-85.
13. Molteni N, Bardella, MT, Bianchi PA. Obstetric and gynecological problems in women with untreated celiac sprue. J Clin Gastroenterol 1990;12:37-39.
13. Akerlund M, Anderson KE, Ingemarsson I. Effect of terbutaline on myometrial activity, endometrial blood flow, and lower abdominal pain in women with primary dysmenorrhoea. Br J Obstet Gynaecol 1976;83:673-78.
14. Lundstrom V, Green K. Endogenous levels ofprostaglandin F2alpha and its main metabolites in plasma and endometrium of normal and dysmenorrheic women. Am J Obstet Gynecol 1978;130:640-46.
15. Stromberg P, Akerlund M, Forsling ML, Granstrom E, Kindahl H. Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea. Acta Obstet Gynecol Scand 1984;63:533-38.
16. Forsling ML, Stromberg P, Akerlund M. Effect of ovarian steroids on vasopressin secretion. J Endocrinol 1982;95:147-51.
17. Harlow SD, Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol 1996;103:1134-42.
18. Sultan C, Jeandel C, Paris F, Trimeche S. Adolescent dysmenorrhea. Endocr Dev 2004;7:140-47.